收藏切换
The regulation of FFAR1 on insulin secretion and the development of related drugs
收藏切换
PDF
Wei-hua JIA, Xiu-ying YANG*, Guan-hua DU*
Acta Pharmaceutica Sinica | 2018, 53(11) : 1770 - 1777
Less
收藏切换
Acta Pharmaceutica Sinica | 2018, 53(11): 1770-1777
REVIEWS
The regulation of FFAR1 on insulin secretion and the development of related drugs
Full
Wei-hua JIA, Xiu-ying YANG*, Guan-hua DU*
Affiliations
  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Matria Medica, Chinese Accademy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
Published: 2018-11-12 doi: 10.16438/j.0513-4870.2018-0599
Outline
收藏切换

Free fatty acid receptor 1 (FFAR1), also known as G protein-coupled receptor 40 (GPR40), is a receptor for diverse free fatty acids. This review aims at summarizing effects and mechanisms of FFAR1 on insulin secretion and related blood glucose and lipids metabolism. FFAR1 is involved in the occurrence and development of type 2 diabetes, but its specific mechanism has not been clarified. FFAR1 is expressed in the wide variety of issues, especially β-cells in the pancreatic islets, as well as α-cells in islets, central nervous tissue, subcutaneous fat, skeletal muscle, gastrointestinal tract, etc. FFAR1 can act on islet β-cells to promote the secretion of insulin, promote α-cells on glucagon secretion, and regulate the secretion of endocrine cells in the gastrointestinal tract to balance the level of glucose and lipids. Existing research found that FFAR1 agonists have significant advantages. They promote insulin release, reduce weight and protect pancreatic β-cells, and have no risk of hypoglycemia. To in-depth understand the role of FFAR1 as a drug target in the treatment of diabetes, further pharmacological studies are still needed in order to obtain safer and more effective drugs against type 2 diabetes.

free fatty acid receptor 1  /  type 2 diabetes  /  free fatty acid  /  insulin
Wei-hua JIA, Xiu-ying YANG, Guan-hua DU. The regulation of FFAR1 on insulin secretion and the development of related drugs[J]. Acta Pharmaceutica Sinica, 2018 , 53 (11) : 1770 -1777 . DOI: 10.16438/j.0513-4870.2018-0599
Year 2018 volume 53 Issue 11
PDF
144
66
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2018-0599
  • Receive Date:2018-06-30
  • Online Date:2026-01-15
  • Published:2018-11-12
Article Data
Affiliations
History
  • Received:2018-06-30
  • Revised:2018-08-15
Funding
Affiliations
    State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Beijing Key Laboratory of Drug Target Identification and Drug Screening, Institute of Matria Medica, Chinese Accademy of Medical Sciences and Peking Union Medical College, Beijing 100050, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2018-0599
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT